Chemours (NYSE: CC) reported Q4 EPS of $0.56, $0.14 better than the analyst estimate of $0.42. Revenue for the quarter came in at $1.4 billion versus the consensus estimate of $1.35 billion.

GUIDANCE:

Chemours sees FY2020 EPS of $2.60-$3.55, versus the consensus of $3.16.

For earnings history and earnings-related data on Chemours (CC) click here.